R&D & Tech
46 articles
Thai Study: Cannabis–Turmeric Cream May Improve Eczema and Psoriasis Symptoms, Showing Antioxidant and Anti-Inflammatory Activity
Researchers at Thailand’s Prince of Songkla University and Thaksin University reported that a topical cream containing cannabis and turmeric extracts may have potential for eczema and psoriasis. The study, published in Cosmetics, found antioxidant and anti-inflammatory activity, but larger human clinical studies are required to establish real-world therapeutic efficacy.
2026-08-14
CBD Hydrogel Strongly Inhibits Staph Bacteria Without Harming Human Skin Cells — ACS Omega Study
A study published in ACS Omega found that a CBD-loaded hydrogel strongly inhibited Staphylococcus aureus, a leading cause of skin and soft-tissue infections, without showing toxicity to human skin cells. The early work suggests potential as a topical treatment for infected wounds, though clinical safety and efficacy remain to be established.
2026-08-14
Université Laval Study: CBD Inhibits Dental-Plaque Bacteria and Biofilm Formation While Preserving Gum-Cell Viability
Researchers at Canada’s Université Laval reported in the International Journal of Dentistry that CBD inhibited growth and biofilm formation of Streptococcus oralis, a bacterium involved in early dental-plaque formation, while preserving human gum-cell viability at the tested concentrations. The findings suggest oral-health potential, but further research is needed before translation into products or treatment.
2026-08-14
Systematic Review Finds Antidepressant-Like Effects of CBD Through Neuroplasticity, Inflammation and Neurotransmission Pathways
A systematic review by Brazilian researchers examining experimental studies from the past five years concluded that CBD may have antidepressant-like effects. It identifies multiple possible biological pathways, including neuroplasticity, inflammation regulation and neurotransmitter signaling, while underscoring the need for more human studies before clinical application.
2026-08-13
Researchers Identify 227 Cannabis Terpenes and Map Genetic Drivers of Cultivar-Specific Aromas
A study published in Acta Pharmaceutica Sinica B identified 227 cannabis terpenes and mapped genetic mechanisms that shape cultivar-specific aroma and terpene profiles. By combining genome sequencing, metabolite measurement, gene-expression analysis and enzyme assays, the work offers a resource for cultivar development and constituent-standardization research.
2026-08-13
Government Study Links Workers’ Compensation Coverage of Medical Cannabis to Better Health and Lower Opioid Use
A government study suggests that coverage of medical cannabis through workers’ compensation may be associated with improved patient health and lower opioid use. The research expands the policy evidence for incorporating medical cannabis into reimbursement systems and points to a potential alternative approach to pain management and opioid dependence.
2026-08-12
CDC Study Finds Sharp Rise in Cannabis Hyperemesis Syndrome Prevalence from 2016 to 2022
A U.S. Centers for Disease Control and Prevention study reported a sharp rise from 2016 to 2022 in the prevalence of cannabis hyperemesis syndrome (CHS), a condition marked by recurrent nausea and vomiting associated with frequent cannabis use. The findings highlight the need to better understand cannabis-related health risks and strengthen clinical and public-health responses.
2026-08-12
Dronabinol (THC) Significantly Reduces Frequency and Intensity of PTSD Nightmares — Successful Randomized Clinical Trial in 171 Participants
Dronabinol, a THC-containing pharmaceutical, significantly reduced the frequency and intensity of nightmares in patients with PTSD. In a randomized clinical trial involving 171 participants, the drug produced positive results, supporting its potential as a therapeutic option for PTSD.
2026-08-05
Ege University (Türkiye) Develops Microbial Processing Technology for Hemp — Optimizes Component Utilization
Ege University in Türkiye has developed a process technology that optimizes the utilization of hemp constituents through controlled microbial fermentation. The research opens new possibilities in hemp biotechnology and is expected to help increase the value of industrial hemp by improving extraction and conversion of target components.
2026-08-04
CBD Provides Post-LASIK Pain Relief Comparable to Codeine–Acetaminophen — Clinical Trial
A clinical trial found that CBD produced pain relief after LASIK comparable to a codeine–acetaminophen combination. The result highlights CBD as a potential new option for ophthalmic postoperative pain management and suggests it may serve as an alternative to opioid analgesics.
2026-08-03
CBD Reduces Joint Inflammation, Synovial Angiogenesis and Bone Destruction in a Rheumatoid Arthritis Ku Model (Phytomedicine)
A study published in Phytomedicine found that CBD reduced joint inflammation, aberrant synovial angiogenesis and bone destruction in a rheumatoid arthritis Ku model. Researchers at Hunan University of Chinese Medicine examined whether inhibiting synovial angiogenesis could delay disease progression and report that CBD does not act primarily by directly suppressing synovial fibroblast hyperactivity; rather, it blocks pro‑angiogenic signaling between synovial cells and endothelial cells. These findings highlight CBD’s potential as a disease‑modifying, anti‑angiogenic therapeutic approach for rheumatoid arthritis.
2026-08-01
Cannabis May Improve Symptom Control and Reduce Medication Dependence in Inflammatory Bowel Disease — Quality of Life Improved (IBD Study)
The study suggests that cannabis may help control symptoms and lower reliance on medications in patients with inflammatory bowel disease (IBD), resulting in improved quality of life. It is being considered as an alternative option for IBD patients, including those with Crohn’s disease and ulcerative colitis, to reduce the side effects associated with conventional drugs such as steroids.
2026-07-29